Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
UCB [BE0003739530/UCB]   
[08/11/2017]

UCB : UCB Media Room: New study data presented at ISPOR

New study data shows prior osteoporotic fractures put women at increased risk of future major osteoporotic fracturesRisk of a subsequent fracture was highest within the first two years after the previous fracture according to Swedish observational study1Prior vertebral fracture led to a higher risk of subsequent fracture compared to prior hip or any other fragility fracture1BRUSSELS, Belgium 8th... See more
 
UCB [BE0003739530/UCB]   
[06/11/2017]

UCB : UCB Media Room: UCB Dermira Collaboration

Dermira and UCB Agree to End Collaboration Agreement for CIMZIADermira to transition development and commercialization responsibility for CIMZIA® certolizumab pegol in psoriasis back to UCBDecision reflects both companies’ strategic prioritiesUCB remains committed to bringing CIMZIA to psoriasis patients upon regulatory approvalMENLO PARK, Calif. and BRUSSELS, Belgium, Nov. 6, 2017 –... See more
 
UCB [BE0003739530/UCB]   
[06/11/2017]

UCB : UCB Media Room: ACR curtain raiser

UCB Presents New Findings Advancing Patient Care for Chronic Inflammatory Diseases and Osteoporosis at 2017 ACR/ARHP Annual MeetingKey data focus on inflammatory and osteoporosis in patient populations with unmet needs including women of childbearing age and others:The results from the firstofitskind CRIB study demonstrate minimal placental transfer of CIMZIA® during pregnancy;an additional... See more
 
UCB [BE0003739530/UCB]   
[06/11/2017]

UCB : UCB Media Room: Vimpat US Pediatric Approval

UCB’s VIMPAT® lacosamide now approved by FDA to treat partialonset seizures in pediatric epilepsy patientsVIMPAT® lacosamide CV oral formulations are approved as a monotherapy or adjunctive therapy in patients four years of age and older with partialonset seizures POS1Pediatric epilepsy is the most common, serious, treatable neurological disorder among children and young adults, thought to... See more
 
UCB [BE0003739530/UCB]   
[20/10/2017]

UCB : UCB Media Room: Q3 results 2017

UCB First Nine Months Interim Report 2017:Strong 9 months performance allows for increase of 2017 financial outlookBrussels Belgium, 20 October 2017 – 7:00 CEST – regulated information –Revenue increased to € 3.3 billion, by 9%; main products grew by 15% to € 2.6 billionR&D update: Briviact® approved as monotherapy in the U.S. Vimpat® approved as monotherapy in Japan and for children... See more
 
UCB [BE0003739530/UCB]   
[20/10/2017]

UCB : UCB Media Room: World Osteoporosis Day

By the time you finish reading this headline another person will have suffered a fragility fracture due to osteoporosis1BRUSSELS, BELGIUM October 20, 2017 – Osteoporosis is a major public health concern which affects more than 200 million people worldwide.2 Every three seconds someone will break a bone due to osteoporosis.1 That’s almost 9 million fractures per year.3 Despite this, only 20%... See more
 
UCB [BE0003739530/UCB]   
[13/10/2017]

UCB : UCB Media Room: Transparency Notification The Capital Group Companies

Transparency notification The Capital Group CompaniesBrussels Belgium, 13 October – 20:00 CEST – regulated information1. Summary of the notificationPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification dated 12 October 2017 from The Capital Group Companies, Inc. having its registered... See more
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Currencies
DOLLAR US 17/11 0.8478€ -0.20%
LIVRE STERLING 17/11 1.1187€ -0.23%
FRANC SUISSE 17/11 0.8550€ -0.09%
YEN 17/11 0.0075€ +0.23%

BEL 20 top gainers
UMICORE 18:07 38.500€ +0.35%
DELHAIZE GRO 17:36 102.800€ +0.29%
UMICORE 17:35 75.250€ +0.23%
SOLVAY 17:35 121.050€ +0.04%
D'IETEREN 17:35 38.650€ +0.01%

BEL 20 top losers
KBC 17:35 67.380€ -3.25%
UCB 17:35 61.410€ -2.06%
ELIA 17:35 49.045€ -1.72%
COFINIMMO 17:35 107.450€ -1.33%
TELENET GROU 17:35 58.620€ -1.01%

Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news of UCB